# A Phase I Study to Investigate the ADME of KD101

> **NCT02819934** · PHASE1 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 6 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** KD101

## Key facts

- **NCT ID:** NCT02819934
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-20
- **Primary completion:** 2016-06-06
- **Final completion:** 2018-12-15
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02819934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02819934, "A Phase I Study to Investigate the ADME of KD101". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02819934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*